β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 108, Issue 12, Pages 2485-2494
Publisher
Springer Nature
Online
2013-05-22
DOI
10.1038/bjc.2013.205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
- (2015) Eddy Pasquier et al. Oncotarget
- Bcl-2—Enhanced Efficacy of Microtubule-Targeting Chemotherapy through Bim Overexpression: Implications for Cancer Treatment
- (2015) Amandine Savry et al. NEOPLASIA
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
- (2013) H. M. Wang et al. ANNALS OF ONCOLOGY
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
- (2012) Eddy Pasquier et al. ANGIOGENESIS
- Propranolol Induces Regression of Hemangioma Cells Through HIF-1α–Mediated Inhibition of VEGF-A
- (2012) Harvey Chim et al. ANNALS OF SURGERY
- Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling
- (2012) Donald M. Lamkin et al. BRAIN BEHAVIOR AND IMMUNITY
- Impact of beta blockers on epithelial ovarian cancer survival
- (2012) Elena S. Diaz et al. GYNECOLOGIC ONCOLOGY
- Multi-Parametric Analysis and Modeling of Relationships between Mitochondrial Morphology and Apoptosis
- (2012) Yara Reis et al. PLoS One
- Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma
- (2011) Vincenzo De Giorgi et al. ARCHIVES OF INTERNAL MEDICINE
- Microtubule-targeted agents: When mitochondria become essential to chemotherapy
- (2011) A. Rovini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
- (2011) S. Lemeshow et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.
- (2011) Steven W. Cole et al. CLINICAL CANCER RESEARCH
- β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction
- (2011) Tao Shan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome
- (2011) Denise Josephina Johanna Hermans et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
- (2010) E. K. Sloan et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Carvedilol in glioma treatment alone and with imatinib in vitro
- (2010) Erguven INTERNATIONAL JOURNAL OF ONCOLOGY
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Giant, Dopamine Secreting Thoracoabdominal Neuroblastoma in a 2-year-old: Rapid Preoperative Blockade With Labetalol
- (2010) Lisbeth Pappas et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
- (2010) E. Pasquier et al. MOLECULAR CANCER THERAPEUTICS
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro
- (2010) Xinhua Liao et al. Radiation Oncology
- Catecholamine-secreting neuroblastoma in a 4-month-old infant: perioperative management
- (2009) Michael R. Hernandez et al. JOURNAL OF CLINICAL ANESTHESIA
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Histological profile of tumours from MYCN transgenic mice
- (2008) H C Moore et al. JOURNAL OF CLINICAL PATHOLOGY
- Propranolol for Severe Hemangiomas of Infancy
- (2008) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started